MoneyWorks4Me

Everest Organics - Quaterly Results

13 Aug 2024 Evaluate
The sales is pegged at Rs. 324.46 millions for the June 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 426.70 millions during the year-ago period.The Net Loss for the quarter ended June 2024 is Rs. -60.89 millions as compared to Net Profit of Rs. 0.34 millions of corresponding quarter ended June 2023Operating profit Margin for the quarter ended June 2024 slipped to -33.32% as compared to 27.41% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 324.46 426.70 -23.96 324.46 426.70 -23.96 1972.41 1830.48 7.75
Other Income 3.25 2.20 47.73 3.25 2.20 47.73 8.86 69.44 -87.24
PBIDT -33.32 27.41 -221.56 -33.32 27.41 -221.56 118.72 78.73 50.79
Interest 12.88 12.89 -0.08 12.88 12.89 -0.08 54.66 33.10 65.14
PBDT -46.20 14.52 -418.18 -46.20 14.52 -418.18 64.06 45.63 40.39
Depreciation 14.68 12.94 13.45 14.68 12.94 13.45 57.95 44.74 29.53
PBT -60.88 1.58 -3953.16 -60.88 1.58 -3953.16 6.11 0.89 586.52
TAX 0.01 1.24 -99.19 0.01 1.24 -99.19 4.71 2.72 73.16
Deferred Tax 0.01 0.84 -98.81 0.01 0.84 -98.81 3.71 2.57 44.36
PAT -60.89 0.34 -18008.82 -60.89 0.34 -18008.82 1.40 -1.83 -176.50
Equity 80.00 80.00 0.00 80.00 80.00 0.00 80.00 80.00 0.00
PBIDTM(%) -10.27 6.42 -259.87 -10.27 6.42 -259.87 6.02 4.30 39.94
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..